|
|
 |
|
Viewing report
|
|
|
|
The Royalty Rate Report 2010: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
PharmaVentures, March 2010, Pages: 160
The Definitive Industry Reference, this report is a 'must read' for anyone involved in deal making who wants to get the maximum value from their next
deal.
The report sets out to give the reader a full insight into determining valuation and royalties and the huge impact that these terms can have on deals and their ultimate survival.
This new PharmaDeals Report is an essential component in the tool kit of everyone directly or indirectly involved in royalty rates, value determination, deal structuring, deal negotiation or otherwise concerned with maximising the value of pharmaceutical product and technology transactions.
For new licensing executives the Report provides a basis for formulating value, understanding how value is split between licensor and licensee and deriving sensible licensing terms. For the experienced licensing executives, if you become stuck in negotiations regarding suitable terms for a transaction, the Report can serve to broaden your perspectives on alternative royalty structures.
This best selling report has been comprehensively reviewed and revised to ensure it is up to the minute for 2010 with new data, tables and figures, additional assessment on recent deals, and new commentary on the effect of the credit crunch on Royalty Rate deals.
It provides:
- Clear guidance on the best methodologies to use when calculating Royalty Rates to assist with vital decision making
- Opinions and advice from leading industry deal makers on how to calculate Royalty Rates
- Contextual information - The report reviews the appropriate methodologies to use as part of the process to calculate Royalty Rates in-depth. It explores questions such as: 'What do royalties mean in terms of value?' and'Where do royalties fit within the deal?' Duplicated above
- More case studies - PharmaVentures highlights the issues and pitfalls so that you can avoid them
Customers who bought this item also bought
Guide to Valuation of Pharmaceutical Licensing Deals
Trends in Pharmaceutical Deal Making: An Analysis of Valuations, Deal Structures and Deal Types
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech, 2nd Edition
Discovery Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition
How to License Pharmaceutical Assets
Pharmaceutical Deal Structures - The Essential Manual for Deal Makers
Effective Deal Making in Drug Delivery
Pre-Clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition
Valuing and Structuring Pharmaceutical Licensing Agreements
Oncology Partnering Agreements in Pharma, Biotech and Diagnostics
Vitacon Drug Valuation Model™
Product and Asset Purchase Agreements in Pharma, Biotech and Diagnostics
|
|
|
|
